Pharmabiz

Boston Scientific appoints Joseph M. Fitzgerald as executive vice president and COO

Boston Scientific Corporation, a global medical technology leader, announced the appointment of Joseph M. Fitzgerald to ...
Pharmabiz

MUVON Therapeutics announces positive 12-month phase 2 follow-up data confirming durable efficacy of its first-in-class muscle regeneration therapy in stress urinary incontinence

MUVON Therapeutics announces positive 12-month phase 2 follow-up data confirming durable efficacy of its first-in-class muscle regeneration therapy in stress urinary incontinence: ...
Pharmabiz

Serum Institute of India's HPV vaccine Cervavac receives WHO prequalification

Serum Institute of India's HPV vaccine Cervavac receives WHO prequalification: Our Bureau, Mumbai Thursday, October 8, 2026, 14:10 Hrs [IST] Cervavac, India’s first indigenously ...
Pharmabiz

Akums Drugs unveils next-generation portfolio of moisturization formulations

Akums Drugs unveils next-generation portfolio of moisturization formulations: Our Bureau, Mumbai Thursday, October 8, 2026, 13:40 Hrs [IST] As India moves towards the winter skinc ...
Pharmabiz

Gland Pharma to invest USD 21 million in US subsidiary

Gland Pharma Limited, at its meeting held has considered and approved Investment of USD 21 million by the company in Gland Pharma USA Inc, proposed to be a wholly-owned subsidiary of the company.
Pharmabiz

Motherhood Hospitals in collaboration with Fetal Medicine & Genetics Centre, hosts “Fetal Dialogues 2026”

Motherhood Hospitals, in collaboration with Fetal Medicine & Genetics Centre, hosted “Fetal Dialogues 2026” on October 3–4 at The Leela Ambience, Gurugram, a groundbreaking conference aimed at ...
Pharmabiz

Qiagen expands AI-powered bioinformatics for research and drug discovery

Qiagen expands AI-powered bioinformatics for research and drug discovery: Venlo, Netherlands Thursday, October 8, 2026, 13:00 Hrs [IST] Qiagen N.V., a global leader in Sample to I ...
Pharmabiz

ViiV Healthcare’s long-acting HIV treatment Cabenuva meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia

ViiV Healthcare’s long-acting HIV treatment Cabenuva meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia: London, UK Thursday, Oct ...
Pharmabiz

Cognizant expands AI-enabled DevOps capabilities for Gilead Sciences

Cognizant expands AI-enabled DevOps capabilities for Gilead Sciences: Our Bureau, Bengaluru Thursday, October 8, 2026, 11:30 Hrs [IST] Cognizant announced a five-year extension of ...
Pharmabiz

WHO issues first global guidelines on child and adolescent obesity

WHO issues first global guidelines on child and adolescent obesity: Geneva Thursday, October 8, 2026, 10:00 Hrs [IST] The World Health Organization (WHO) released its first guidel ...
Pharmabiz

Opportunity for clinical research leaders lies in translating regulatory expectations into practical execution: Durga Mane

Opportunity for clinical research leaders lies in translating regulatory expectations into practical execution: Durga Mane: Yash Ved, Mumbai Thursday, October 8, 2026, 08:00 Hrs [ ...
Pharmabiz

National Institute of Naturopathy invites applications for BNYS Degree Programme for Academic Session 2026–27

National Institute of Naturopathy invites applications for BNYS Degree Programme for Academic Session 2026–27: Our Bureau, Mumbai Thursday, October 8, 2026, 09:00 Hrs [IST] The ...